Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

100.80 +0.46 (+0.46%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test 
From Myriad Genetics, Inc.
Via GlobeNewswire
Agrigenomics Market Is Booming Worldwide : Illumina, LGC, Eurofins USA
Stay up-to-date with Agrigenomics Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Illumina, Inc. (NASDAQ: ILMN) is a Leading Gainer in Monday Morning Trading
Via Investor Brand Network
Next Generation Sequencing Market Projected to Show Strong Growth : Life Technology, Biomatters, CLC Bio, GATC Biotech
Get an extensive Next Generation Sequencing Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
A Comprehensive Study Exploring Viral Disease Diagnosis Market : Key Players BioMerieux, Prescient Medicine Holdings, Danaher
AMA released Viral Disease Diagnosis Market research study .Check what differences transitions in customer choices may bring? 
Via SBWire
Creative Biolabs’ Innovative Microbial Identification Solutions Propel Live Biotherapeutic Research
Via Get News
Medical Stocks Waters, Agilent, Illumina Show Growth Potential
Medical-sector stocks Waters, Agilent, and Illumina appear to be trading at low valuations relative to their future growth prospects, according to analysts. 
Via MarketBeat
Nephroblastoma Pipeline, NDA Approvals, Clinical Trials, and Emerging Drugs (2023) | Companies – Clarity Pharma, Y mAbs Therapeutics, Nova Biopharma, Eli Lilly, Illumina Radiopharma, Recombio and Other
Via AB Newswire
Hestia Insight Inc. Signs Letter of Intent With Major Asian-Pacific Health Care Products Distributor
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Will Forced Divesture Of Grail Boost Illumina Shareholder Value?
Regulators may force Illumina to divest Grail, which it acquired in 2021. Carl Icahn is also calling for a divestiture. The move could benefit shareholders. 
Via MarketBeat
Realtimecampaign.com Discusses Some of the Many Benefits of Genotyping
Via Get News
DNA Data Storage Alliance Announces Board Appointments
From DNA Data Storage Alliance
Via Business Wire
Next Generation Sequencing Technology Market 2023 Innovation, Application, Future Trends, Outlook by Type, Application and Business Opportunities to 2030
Next Generation Sequencing Technology Market Growth and Outlook 2023-2030 SWOT Analysis by Key Players – Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life... 
Via SBWire
Universal Sequencing Technology Corporation Launches High-Throughput Solution For Microbial WGS Library Preparation
CARLSBAD, Calif. - March 14, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announced today the release of a high throughput... 
Via PRLog
Topics Intellectual Property
DNA Sequencing and Service Market May See a Big Move : Abbott Laboratories, Eurofins Scientific, Illumina
Stay up-to-date with DNA Sequencing and Service Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry 
From Myriad Genetics, Inc.
Via GlobeNewswire
Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023
Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),... 
Via SBWire
Topics Economy
Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029
Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,... 
Via SBWire
New Survey Data Shows Innovation Teams at Large Companies Are Focusing More on Near-Term Initiatives, but Internal Politics and Culture Remain Top Challenges
InnoLead has released a 2023 update to its popular Benchmarking Innovation Impact research with KPMG LLP. 
Via Newswire.com
Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory
The modern laboratory complex, complete with genomic sequencers and microarray analysis platforms from the U.S. company Illumina, helps solve problems in medical research and agriculture. In addition... 
Via PRUnderground
Topics Economy
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection
From GRAIL, LLC
Via Business Wire
Universal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech
CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key... 
Via PRLog
Topics Intellectual Property
Universal Sequencing Technology Corporation Announces High-Throughput Solution For NGS Library Preparation
UST releases high-throughput solution enabling second-generation short-read sequencers to produce long-range results in greater capacity.CARLSBAD, Calif. - Oct. 24, 2022 - PRLog -- Universal Sequencing... 
Via PRLog
Topics Intellectual Property
Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –
This press release was orginally distributed by SBWire 
Via ReleaseWire
Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –
London, UK -- (SBWIRE) -- 10/18/2022 -- The latest publication titled Companion Diagnostics – Thematic Research has been added to GlobalData Plc report store. Companion diagnostics (CDx) are molecular... 
Via SBWire
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027
Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing... 
Via FinancialNewsMedia
Is Illumina Still the Gamechanger in Genomics Sequencing?
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused 
Via MarketBeat
Topics Earnings Economy Lawsuit
CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service
Via Get News
Agilent Technologies Proves Its Worth VS Illumina
Agilent Technologies (NYSE: A) is a highly-valued stock for the low 0.6% dividend that it pays but the Q2 results once again prove the company’s worth. The results include a top and bottom line beat as... 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.